Teladoc

Teladoc

Price: 7.03

Company and Business Model

Teladoc Health, Inc. is a telehealth company that provides virtual healthcare services, including medical consultations, mental health support, and chronic condition management. Its core offerings encompass a range of telemedicine solutions, leveraging technology to connect patients with healthcare professionals. Major business segments include primary care, mental health, and specialty care services. The company generates revenue primarily through subscription fees and per-visit charges for its telehealth services.

Investment Profile

The investment profile of Teladoc suggests it may be more aligned with growth investors, given its focus on expanding telehealth services in a rapidly evolving market. However, the current financial metrics indicate challenges, which may deter those seeking stable dividends or value opportunities. Investors should consider the potential for recovery against the backdrop of elevated risk factors.

Official website

Fundamental metrics (experimental)

EPS (TTM) — earnings per share for the last 12 months, $
-0.97 Risk
Revenue QoQ — quarter-over-quarter revenue growth
-4.4%
EPS surprise
-5.5% worse than expected
20d volatility
4.1% stable
FMP / FinFeed data updated: 2026-06-11
Reco: Sell Potential: 30 Risk: 69 Updated: 2026-06-11 05:26
How recommendation works
Why AI thinks so:
Weak fundamentals and negative momentum raise significant concerns.

Track in portfolio

Price chart

AI recommendation Analyst forecast Calendar event Positive signal Negative signal Neutral / update Hold / informational B My buy S My sell
AI recommendation changes
Date Before After Reason
2026-06-09 02:52 Hold Sell Weak fundamentals and negative momentum signal high risk.
2026-06-01 02:51 Sell Hold Weak fundamentals and high risk limit upside potential.
2026-05-08 15:29 Sell Weak fundamentals and high risk limit upside potential.
Analyst forecasts
Date Analyst Action Target Price Then
2026-04-08 13:16 Evercore ISI Target Raised 5 → 6 5.27
2026-03-10 10:06 Deutsche Bank Update — → 11 5.575
2026-02-26 13:20 Stifel Nicolaus Target Lowered — → 6 5.07
Amazon CrowdStrike Nvidia Rivian Automotive Teladoc Novo Nordisk Gilead Sciences Qualcomm

Аналитики Bank of America понизили рейтинг Qualcomm (QCOM) до «недостаточно» из-за слабого роста, в то время как Nvidia (NVDA) остается в списке «покупать»

На Уолл-стрит в последние дни произошло несколько значительных изменений в рекомендациях аналитиков.